BACKGROUND: Exhausted T cells and regulatory T cells (Tregs) comprise diverse subsets of tumor immunosuppressive microenvironment that play key roles in tumor progress. Understanding subset diversity in T cells is a critical question for developing cancer immunotherapy. METHODS: A total of 235 specimens from surgical resections of hepatocellular carcinoma (HCC) patients were examined for infiltration of exhausted T cell (Tex) in tumor and adjacent tissue. We conducted deep single-cell targeted immune profiling on CD3 RESULTS: We observed transitional differentiation of exhausted CD8 CONCLUSIONS: T cell exhaustion is a progressive process, and the gene-expression profiling displayed T cell exhaustion and anergy are different. Accordingly, it...
IntroductionMounting evidence has revealed that the interactions and dynamic alterations among immun...
Background/Aims: Regulatory T cells (Tregs) are associated with a poor prognosis in hepatocellular c...
Immunotherapy is a powerful therapeutic strategy for end-stage hepatocellular carcinoma (HCC). It is...
Background & Aims: Despite recent translation of immunotherapies into clinical practice, the immunob...
Background/AimsHepatocellular carcinoma (HCC), accounting for 75-85% of primary liver cancer cases, ...
Systematic interrogation of tumor-infiltrating lymphocytes is key to the development of immunotherap...
[[abstract]]Background: Reversal of CD8 T-cell exhaustion was considered a major antitumor mechanism...
Despite the success of monotherapies based on blockade of programmed cell death 1 (PD-1) in human me...
Background: Reversal of CD8 T-cell exhaustion was considered a major antitumor mechanism of anti-pro...
The first gene profiling study of cancer-specific CD8+ T-cells demonstrates that lymphocyte dysfunct...
In T-cell biology, ‘exhaustion’ was initially described as a hyporesponsive state in CD8+ T cells du...
T-cell exhaustion was originally identified during chronic infection in mice, and was subsequently o...
Diseases such as cancer are often associated with suppression of the immune sys- tem. Thereby, cytot...
BACKGROUND & AIMS: Agents that induce an immune response against tumors by altering T-cell regulatio...
Abstract In hepatocellular carcinoma (HCC), γδ T cells participate in mediating the anti‐tumour resp...
IntroductionMounting evidence has revealed that the interactions and dynamic alterations among immun...
Background/Aims: Regulatory T cells (Tregs) are associated with a poor prognosis in hepatocellular c...
Immunotherapy is a powerful therapeutic strategy for end-stage hepatocellular carcinoma (HCC). It is...
Background & Aims: Despite recent translation of immunotherapies into clinical practice, the immunob...
Background/AimsHepatocellular carcinoma (HCC), accounting for 75-85% of primary liver cancer cases, ...
Systematic interrogation of tumor-infiltrating lymphocytes is key to the development of immunotherap...
[[abstract]]Background: Reversal of CD8 T-cell exhaustion was considered a major antitumor mechanism...
Despite the success of monotherapies based on blockade of programmed cell death 1 (PD-1) in human me...
Background: Reversal of CD8 T-cell exhaustion was considered a major antitumor mechanism of anti-pro...
The first gene profiling study of cancer-specific CD8+ T-cells demonstrates that lymphocyte dysfunct...
In T-cell biology, ‘exhaustion’ was initially described as a hyporesponsive state in CD8+ T cells du...
T-cell exhaustion was originally identified during chronic infection in mice, and was subsequently o...
Diseases such as cancer are often associated with suppression of the immune sys- tem. Thereby, cytot...
BACKGROUND & AIMS: Agents that induce an immune response against tumors by altering T-cell regulatio...
Abstract In hepatocellular carcinoma (HCC), γδ T cells participate in mediating the anti‐tumour resp...
IntroductionMounting evidence has revealed that the interactions and dynamic alterations among immun...
Background/Aims: Regulatory T cells (Tregs) are associated with a poor prognosis in hepatocellular c...
Immunotherapy is a powerful therapeutic strategy for end-stage hepatocellular carcinoma (HCC). It is...